Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Copt Defense Properties (CDP)

Copt Defense Properties (CDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
COPT Defense Increases Quarterly Dividend by 4.9%

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.32 per common share for the first quarter...

CDP : 31.73 (+0.70%)
COPT Defense: Q4 Earnings Snapshot

COPT Defense: Q4 Earnings Snapshot

CDP : 31.73 (+0.70%)
COPT Defense Establishes 2026 Guidance

FFO per Share to Increase 1.1% at Midpoint

CDP : 31.73 (+0.70%)
COPT Defense Reports Strong Full Year 2025 Results

EPS of $1.34 for Full Year FFO per Share, as Adjusted for Comparability, of $2.72 Increased 5.8% Over 2024 Results ...

CDP : 31.73 (+0.70%)
COPT Defense Executes Full Building Lease with Top 10 U.S. Defense Contractor at 400 National Business Parkway

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) executed a 148,000 square foot lease with a top 10 U.S. Defense contractor at 400 National Business Parkway for a lease term...

CDP : 31.73 (+0.70%)
COPT Defense Announces Tax Treatment of 2025 Distributions

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) announced the 2025 tax treatment of its common share distributions as described below. Shareholders are encouraged to consult...

CDP : 31.73 (+0.70%)
COPT Defense Executes 236,000 Square Foot Build-to-Suit Lease in its Maryland Portfolio

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) executed a build-to-suit lease in January 2026 with a Defense/IT tenant in its Maryland portfolio. The Company’s anticipated...

CDP : 31.73 (+0.70%)
COPT Defense Mourns the Death of Former Chief Executive Officer and Trustee, Roger A. Waesche, Jr.

It is with great sadness that COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) announces the passing of its former CEO and Trustee, Roger A. Waesche, Jr. Mr. Waesche...

CDP : 31.73 (+0.70%)
COPT Defense Executes 132,000 Square Foot Build-to-Suit Lease in San Antonio, Bringing New Investments in 2025 to $277 Million

Exceeds Capital Commitment to New Investments Guidance in 2025

CDP : 31.73 (+0.70%)
COPT Defense Completes 557,000 Square Feet of Vacancy Leasing in 2025, Exceeds Revised Target

COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) completed 557,000 square feet of vacancy leasing in 2025, with a weighted-average lease term of roughly 7.5 years, which exceeded...

CDP : 31.73 (+0.70%)

Barchart Exclusives

Nvidia Dumped Recursion Pharmaceuticals Stock. Should You?
Nvidia sold its position in Recursion Pharmaceuticals, while others keep a measured outlook. Does this divergence signal risk or opportunity? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar